Načítá se...
Silencing dishevelled‐1 sensitizes paclitaxel‐resistant human ovarian cancer cells via AKT/GSK‐3β/β‐catenin signalling
OBJECTIVES: Expression of dishevelled‐1 (DVL1) has recently been linked to cancer progression, however, its role in resistance to cancer therapy is unclear. In this study, we aimed to explore the function of DVL1 in paclitaxel‐resistant human ovarian cancer cells. MATERIALS AND METHODS: The MTT assa...
Uloženo v:
| Vydáno v: | Cell Prolif |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495546/ https://ncbi.nlm.nih.gov/pubmed/25643607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12161 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|